GNS and Servier Announce AI Collaboration

Article

GNS and Servier announced a collaboration to advance drug discovery, translational, and clinical development efforts in Multiple Myeloma (MM).

The collaboration will address key questions about how MM progresses in different patient subpopulations. This work will initially leverage the GNS Gemini Digital Twin for MM developed using the rich clinico-genomic data from the Multiple Myeloma Research Foundation (MMRF) CoMMpass study.

Read more about the new partnership here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.